BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Boehringer Mannheim Corporation's Ben Venue Laboratories to Trim Hundreds of Jobs, Will Cut Production Activity by Year's End


8/20/2013 7:13:14 AM

Ben Venue is cutting jobs but others are hiring! Check it out! (Isn't it tempting?)

A two-paragraph "update" on the web site of Bedford-based Ben Venue Laboratories Inc. says the company will stop drug production in its oldest manufacturing facility by the end of the year. The statement also said production will end in another of its facilities at that time and that several hundred positions will be eliminated. In an email, Boehringer Ingelheim Corp. spokeswoman Marjorie Moeling said Wednesday that for "proprietary reasons" the company does not disclose in which of its four facilities products are manufactured.

Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)



   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES